Lymphangiosarcoma

Image and content excerpted from the VisualDx clinical decision support system.


Image of Lymphangiosarcoma

VisualDx images show variation in age, skin color, and disease stage. VisualDx has 9 images of Lymphangiosarcoma.

Full text and additional images for Lymphangiosarcoma are available in the following VisualDx packages:

Complete

See descriptions of all packages available or sign up for a Free 30-Day Trial of the Essentials Package.


ICD Codes

ICD-9-CM:
171.2 – Malignant neoplasm of connective and other soft tissue of upper limb including shoulder

ICD-10-CM:
C49.10 – Malignant neoplasm of connective and soft tissue of unspecified upper limb, including shoulder

Synopsis

Lymphangiosarcoma (LAS), also known as Stewart-Treves syndrome (lymphangiosarcoma, angiosarcoma, or hemangiosarcoma post-mastectomy), is a rare, aggressive cutaneous angiosarcoma occurring in association with chronic lymphedema. It was originally described in 1948 by Stewart and Treves in six patients with upper extremity lymphedema post-mastectomy. LAS usually affects the upper extremities following axillary lymph node dissection or local radiation therapy for breast carcinoma. Metastases most frequently go to the thoracic cavity and lungs but may also involve other internal organs and bone. LAS has a poor prognosis.

Acute (<18 months) and chronic (>18 months) lymphedema in the upper extremities occurs in 10-35% of patients following radical mastectomy with axillary lymph node dissection or radiotherapy. LAS has been reported to occur in <1% of women between 5 and 15 years post-radical mastectomy with lymphedema. Advances in surgical management of breast carcinoma, including partial mastectomies, sentinel lymph node biopsies, and adjuvant radiation therapy, have significantly decreased the incidence of associated post-surgical lymphedema and cases of LAS. Isolated cases of LAS have also been associated with secondary forms of lymphedema (eg, idiopathic, congenital, trauma induced, morbid obesity, venous stasis, filarial, etc) in humans and animals.

The term lymphangiosarcoma is a misnomer, as the malignant cells of origin arise from vascular endothelial cells rather than from the lymphatics and, therefore, angiosarcoma or hemangiosarcoma would be more appropriate descriptive terms. While the exact etiology of LAS is unknown, it is thought that post-operative hematoma formation, chronic infections, tissue fibrosis, and even local radiation may all create a regional immunodeficient state contributing to the development of LAS.

Pediatric Patient Considerations
LAS can occur with congenital (eg, Milroy's) lymphedema.

Try VisualDx FREE for 30 days

VisualDx is your key to a faster, more accurate diagnosis.

Sign up today and receive a FREE 30-day trial to the VisualDx Essentials Package.

Your VisualDx subscription includes mobile access via our Apple and Android apps.

VisualDx is a web-based clinical decision support system used in over 1,500 hospitals and large clinics. Learn more.

Get your FREE 30-day trial